Results 191 to 200 of about 3,331,814 (239)
Some of the next articles are maybe not open access.

Lichens of Parmelioid Clade as Promising Multitarget Neuroprotective Agents.

Chemical Research in Toxicology, 2019
Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are multifactorial disorders which are increasing in incidence and prevalence over the world without existing effective therapies.
Victor Sieteiglesias   +4 more
semanticscholar   +1 more source

Neuroprotective agents in traumatic brain injury [PDF]

open access: possibleExpert Opinion on Investigational Drugs, 2001
The role of neuroprotection in traumatic brain injury (TBI) is reviewed. Basic research and experimental investigations have identified many different compounds with potential neuroprotective effect. However, none of the Phase III trials performed in TBI have been successful in convincingly demonstrating efficacy in the overall population.
openaire   +3 more sources

Leptin as a neuroprotective agent in glaucoma

Medical Hypotheses, 2013
Glaucoma is a disease characterized by progressive optic nerve degeneration and is the leading cause of irreversible blindness worldwide. More than 60 million people globally are affected by glaucoma, of which 8 million people suffer from bilateral blindness, making glaucoma the second leading cause of bilateral blindness worldwide.
openaire   +3 more sources

Neuropeptides: Potential neuroprotective agents in ischemic injury.

Life Science, 2021
Priyanka Saklani   +4 more
semanticscholar   +1 more source

Neuroprotective Agents

2016
Variations in the physicochemical properties of substituents at the different positions of the coumarin ring were broadly examined under the neurodegenerative disorders, and the results were added to our knowledge for the improvement of compounds that control receptor function.
openaire   +2 more sources

A Review of Agents Patented for their Neuroprotective Properties

Recent Patents on CNS Drug Discovery, 2006
The brain continues to remain an area where little corrective surgery can be performed. Recently, the ability to reverse some brain damage and perhaps prevent further damage has moved closer to hospitals and clinics. Several agents demonstrating neuroprotective properties and even neural regeneration have been developed to the extent that they have ...
Margaret A. Brimble, Mark S. Levi
openaire   +3 more sources

Introduction: Immunosuppressants as Neuroprotective Agents

2003
The discovery that the two most powerful immunosuppressants, cyclosporin A and FK506, are also the most effective neuroprotectants known is profoundly important to neurology. Two drugs that revolutionized the field of organ transplantation as immunosuppressants are beginning to have an even greater impact on medicine in their new role as ...
Eskil Elmér   +2 more
openaire   +2 more sources

Experimental Neuroprotective Agents

Dimensions Of Critical Care Nursing, 1995
Neuroprotective agents are investigational drugs that can potentially suppress the development of secondary brain injury following cerebral traumatic injury. Currently, critical care nurses in research centers are challenged to care for these patients during the clinical trial phase of these drugs.
openaire   +3 more sources

Home - About - Disclaimer - Privacy